Table 5 CMR data for early reperfused versus non-reperfused patients
Variable | Early reperfused (n = 59) | Non-reperfused (n = 21) | p |
|---|---|---|---|
Age (y) | 60.2 ± 11.9 | 65.6 ± 16.2 | 0.11 |
Male sex (%) | 53 (89.8) | 16 (76.2) | 0.12 |
Time admission-CMR (d) | 1.9 (1.2-2.6) | 6.6 (4.8-11.0) | <0.001 |
LVEDVI (ml/m2) | 90.7 (82.4-102.7) | 98.0 (88.1-125.0) | 0.005 |
LVESVI (ml/m2) | 51.4 (45.4-62.6) | 61.1 (54.0-83.6) | 0.002 |
EF (%) | 42.3 ± 7.8 | 35.0 ± 11.3 | 0.002 |
IS (%LVM) | 24.4 ± 15.3 | 23.8 ± 11.5 | 0.87 |
MVO prevalence (n,%) | 33 (55.9%) | 15 (71.4%) | 0.21 |
MVO (%LVM) | 0.4 (0.0-2.9) | 1.3 (0.0-2.8) | 0.36 |